https://www.epo.org/de/boards-of-appeal/decisions/t222008eu1
T 2008/22 (Gaucher's disease/CENTOGENE) vom 16.06.2025
gaucher s disease2008 2216 06
https://www.biospace.com/press-releases/sharp-therapeutics-corp-nominates-clinical-candidate-for-gauchers-disease
Sharp Therapeutics Corp. Nominates Clinical Candidate for Gaucher's Disease - BioSpace
gaucher s diseaseclinical candidatesharptherapeuticscorp
https://www.researchandmarkets.com/reports/6100899/gauchers-disease-epidemiology-forecast
Gaucher's Disease Epidemiology Forecast 2025-2034
Gaucher disease (GD) is brought on by a lack of glucocerebrosidase enzyme activity. It is the most prevalent lysosomal storage disorder and a rare inherited...
gaucher s diseaseepidemiologyforecast20252034
https://www.epo.org/de/boards-of-appeal/decisions/t201345eu1
T 1345/20 (Diagnosis of Gaucher's disease/CENTOGENE) vom 26.09.2023
gaucher s disease